News | November 15, 2022
The company has reported total income of Rs. 114.77 crores during the period ended September 30, 2022.
This is the fifth consecutive year that a Biocon Group company has made it to the Asia lP ELITE list
The voluntary program is the first time the FDA will allow excipient manufacturers to obtain review of certain novel excipients prior to their use in drug formulations.
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 112 million in the U.S. (IQVIA MAT August 2022).
The company has reported total income of Rs. 519.31 crores during the period ended September 30, 2022.
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of US $112 million in the US
The award recognizes Parexel for delivering the best decentralized trial experience for customers through its capabilities, expertise, and patient recruitment and retention strategies
Both the partners will work towards bringing Aster Pharmacy’s in-house quality care products to serve the healthcare needs of the local population in KSA
The hospital has taken a huge step by offering “Titli-palliative care services at home” to provide curative, restorative, and life-prolonging treatment to seriously ill children
Subscribe To Our Newsletter & Stay Updated
